Yong Teng

Has grant

Associate Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yong Teng is an Associate Professor at Emory University in the United States. His research focuses on cancer biology, immunotherapy, and the molecular mechanisms underlying head and neck cancers. Recent publications include studies on neuronal deficiencies, oncolytic virotherapy, and innovative mRNA delivery methods, contributing to advancements in cancer treatment strategies and understanding of tumor immunity.

Recent Grants

Grant: Close

ATAD3A as a novel target in head and neck cancer

Open Date:

Close Date:

Grant: Close

The impact of Arf1 on hypoxia signaling and oral cancer

Open Date:

Close Date:

Grant: Close

Targeting prostate cancer metastasis

Open Date:

Close Date:

Grant: Close

Role of FAT1 somatic mutations in aggressiveness of head and neck cancer

Open Date:

Close Date:

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Tae Jin Lee

Assistant Professor

Augusta University

UNITED STATES

View details

Nabil F. Saba

UNITED STATES

View details

Fatemeh Momen-Heravi

Associate Professor

Columbia University Columbia College

UNITED STATES

View details

Gabriel A. Kwong

UNITED STATES

View details

Ashok Sharma

Augusta University

UNITED STATES

View details

Leidong Mao

College of Engineering

UNITED STATES

View details

Yisang Yoon

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yong Teng

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (27)

Neuronal CDK5RAP3 deficiency leads to encephalo-dysplasia via upregulation of N-glycosylases and glycogen deposition

SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis

Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells

Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell–Mediated Antitumor Immunity by Suppressing ER Stress–Associated THBS2 Signaling

Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient

Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent

Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer

Cell death shapes cancer immunity: spotlighting PANoptosis

Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer

Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes

HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer

Cancer metabolism and carcinogenesis

Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53

Leveraging Saliva for Insights into Head and Neck Cancer

Calcium nanoparticles target and activate T cells to enhance anti-tumor function

Harnessing cancer stem cell-derived exosomes to improve cancer therapy

Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling

Remodeling of Mitochondria in Cancer and Other Diseases

Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

CDK5RAP3, a key defender of udder, modulates NLRP3 inflammasome activation by regulating autophagolysosome degradation in S. agalactiae-infected mastitis.

The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme

Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States

Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development

The mitochondrial fusion protein OPA1 is dispensable in the liver and its absence induces mitohormesis to protect liver from drug-induced injury.

Collaborators (7)

Tae Jin Lee

Nabil F. Saba

Fatemeh Momen-Heravi

Gabriel A. Kwong

Ashok Sharma

Leidong Mao

Yisang Yoon

Make your next move.